Literature DB >> 11319919

Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.

G J Avilés Mendoza1, N E Seidel, M Otsu, S M Anderson, K Simon-Stoos, A Herrera, S Hoogstraten-Miller, H L Malech, F Candotti, J M Puck, D M Bodine.   

Abstract

X-linked severe combined immunodeficiency (XSCID) is caused by mutations in the IL-2 receptor gamma chain (IL2RG) gene, resulting in absent T lymphocytes and nonfunctional B lymphocytes. Recently T lymphocyte production and B lymphocyte function were restored in XSCID patients infused with autologous stem cells transduced with a retrovirus containing the human IL2RG cDNA. To optimize the expression of human IL2RG for future clinical trials, we compared five retroviral vectors expressing human IL2RG from different LTR enhancer-promoter elements in a mouse model. Northern and Southern blot analysis of hematopoietic tissues from repopulated mice revealed that the retroviral vector with the highest expression per copy number was MFG-S-hIL2RG, followed by MND-hIL2RG. All five vectors were capable of restoring lymphopoiesis in irradiated XSCID mice transplanted with transduced IL2RG-deficient hematopoietic stem cells. Transduction of IL2RG-deficient hematopoietic stem cells with all five vectors restored T lymphopoiesis in transplanted stem cell-deficient W/W(v) mouse recipients. However, only XSCID stem cells transduced with the MFG-S-hIL2RG vector generated B lymphocytes in W/W(v) mice. We conclude that the MFG-S-hIL2RG vector provides the best opportunity for in vivo selection and development of B and T lymphocytes for human XSCID gene therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319919     DOI: 10.1006/mthe.2001.0292

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  5 in total

Review 1.  Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.

Authors:  Fabio Candotti
Journal:  Int J Hematol       Date:  2014-02-01       Impact factor: 2.490

2.  Lentiviral-mediated gene transfer to the sheep brain: implications for gene therapy in Batten disease.

Authors:  Kathryn S Linterman; David N Palmer; Graham W Kay; Lucy A Barry; Nadia L Mitchell; Robin G McFarlane; Michael A Black; Mark S Sands; Stephanie M Hughes
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

3.  Transcription factor zinc finger and BTB domain 1 is essential for lymphocyte development.

Authors:  Divya Punwani; Karen Simon; Youngnim Choi; Amalia Dutra; Diana Gonzalez-Espinosa; Evgenia Pak; Martin Naradikian; Chang-Hwa Song; Jenny Zhang; David M Bodine; Jennifer M Puck
Journal:  J Immunol       Date:  2012-06-29       Impact factor: 5.422

4.  The role of diacylglycerol kinase ζ and phosphatidic acid in the mechanical activation of mammalian target of rapamycin (mTOR) signaling and skeletal muscle hypertrophy.

Authors:  Jae-Sung You; Hannah C Lincoln; Chan-Ran Kim; John W Frey; Craig A Goodman; Xiao-Ping Zhong; Troy A Hornberger
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

Review 5.  Partially corrected X-linked severe combined immunodeficiency: long-term problems and treatment options.

Authors:  Suk See De Ravin; Harry L Malech
Journal:  Immunol Res       Date:  2009       Impact factor: 4.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.